AIM ImmunoTech shares rise after DURIPANC trial data show superior survival and safety in metastatic pancreatic cancer ...

Shares of Palantir Technologies are trading flat Monday morning. Investors are digesting a week that saw the stock hit a new all-time high.

Jim Cramer has predicted that Palantir Technologies Inc. will soar to $200, following its recent surge past $150.

Palantir (NYSE: PLTR) has become one of 2025’s most talked-about AI plays, and Jim Cramer isn't hiding his enthusiasm.